Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in Rosacea
NCT01045551Phase 2Completed
- Start
- Jun 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in rosacea. Started Jun 2010; status: completed.
02
Drugs
apremilast
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT01045551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01045551.